Hologic’s 3Dimensions™ System for 3D Mammography Receives EUREF Type Test Certification
Hologic, Inc. (Nasdaq: HOLX) has announced that its 3Dimensions™ mammography system received EUREF Type Test certification, making it the first digital breast tomosynthesis system to achieve this distinction. This certification verifies that the system meets stringent European standards for image quality and radiation exposure. The 3Dimensions system provides enhanced patient comfort, improved workflow for radiologists, and is recognized for its high resolution and speed. This achievement highlights Hologic's commitment to advancing women's health through innovative technology.
- First digital breast tomosynthesis system to receive EUREF Type Test certification.
- Certification assures compliance with high European standards for image quality and radiation exposure.
- Improvements in patient comfort and workflow efficiency for radiologists.
- Recognition boosts brand credibility and aligns with Hologic's mission in women's health.
- None.
3Dimensions System Earns Distinction for Meeting or Exceeding Rigorous European Image Quality and Dose Standards
The mission of the nonprofit EUREF organisation is to raise standards by bringing together the best examples of quality control in mammography screening from regional and national breast cancer programs across
“The work being done by EUREF contributes greatly to ensuring women receive quality screenings and care across
The 3Dimensions system features breakthrough improvements designed to transform the patient experience without compromising on speed, dose or accuracy. The system is the fastest, highest resolution breast tomosynthesis system available,2 and is clinically proven to be more comfortable3 for patients while providing an enhanced workflow for radiologists. In addition to this certification, EUREF has previously certified the company’s Selenia® digital mammography and Selenia Dimensions® 2D systems.
About
Hologic, 3Dimensions, Dimensions and Selenia are trademarks and/or registered trademarks of
Forward-Looking Statements
This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.
This information is not intended as a product solicitation or promotion where such activities are prohibited. For specific information on what products are available for sale in a particular country, please contact a local Hologic sales representative or write to womenshealth@hologic.com.
_____________________________________
1 EUREF. Results EUREF Type test. https://www.euref.org/type-test-equipment/euref-type-test-results. Last accessed
2 Data on file and from public sources, 2017
3 Smith, A. Improving
Source:
View source version on businesswire.com: https://www.businesswire.com/news/home/20221103005150/en/
Media Contact:
Vice President, Corporate Communications
+1.508.263.8764
jane.mazur@hologic.com
Investor Contact
Vice President, Investor Relations
+1.858.410.8514
ryan.simon@hologic.com
Source:
FAQ
What is the significance of Hologic's 3Dimensions mammography system receiving EUREF Type Test certification?
When was the EUREF Type Test certification awarded to Hologic's 3Dimensions system?
What are the key features of the 3Dimensions mammography system?
How many mammography systems have received EUREF Type Test certification?